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CASE REPORT
A 54 year old woman was admitted for cardiac
catheterisation. She had -been attending the
outpatientclinic since 1975, withregularreview.
She had diagnoses of type I osteogenesis
imperfecta, and of supravalvular aortic stenosis.
Osteogenesis imperfecta was diagnosed in early
lifeonclinical grounds includingthepresence of
blue sclerae and the occurrence of several bone
fractures secondarytominimaltrauma. Anumber
offamily members havebeendiagnosed withthe
same condition (figure 1-family pedigree).
The supravalvular aortic stenosis was not
diagnoseduntillater. Shewas initiallyreferredto
the cardiology clinic for further evaluation
following the discovery of a systolic murmur
duringroutineexaminationatanantenatalclinic.
Echocardiography revealed a morphologically
normal aortic valve and confirmed the presence
ofsupravalvularaorticstenosis,withanestimated
peak systolic gradient of 20 mmHg.
Examination of her family history has also
revealed several members with a diagnosis of
supravalvularaortic stenosis (Figure). Neitherof
her parents was known to have had the disease,
buthermotherhaddiedprematurely atthe ageof
42 years supposedly due to asthma. There are
three family members diagnosed with both
osteogenesis imperfectaandsupravalvularaortic
stenosis. Therefore, somemembersofthisfamily
have either supravalvular aortic stenosis or
osteogenesisimperfecta, somehavebothdiseases
and some have neither.
Cardiac catheterisation (SVAS) revealed normal
coronary arteries and left ventricular function.
There was narrowing of the ascending aorta
immediately above the aortic valve with
poststenotic dilatation of the aorta, giving the
typical "hourglass" appearance seen in SVAS.
There was a peak-to-peak gradient of40 mmHg
across the lesion on catheter pull-back.
Karyotyping revealed a normal XX pattern with
nodeletionevident. The mutation causing SVAS
inthisfamilyhasbeenmappedtotheelastingene
on chromosome 7. This family has not yet been
investigated with regard to the molecular basis
for theirosteogenesis imperfecta.
DISCUSSION
Supravalvular aortic stenosis is defined as an
obstructive vascular disease due to severe
narrowing of large elastic arteries, particularly
theascendingaorta,andincludingthepulmonary,
coronary and carotid arteries. The incidence of
the disease is estimated at I in 20,000 births. The
large majority of cases are familial, with
transmission of the disease in an autosomal
dominant manner'. The disease is caused by
mutation in the elastin gene (ELN), located at
chromosome 7qll.232. Supravalvular aortic
stenosis is also a common feature of Williams'
syndrome, a congenital multisystem disorder
caused by contiguous gene deletion that may
include the elastin gene3.
Osteogenesis imperfecta is an inherited
connective tissue disorder, characterized by
skeletal,ocular,otologicanddentalabnormalities
with an incidence of around one in 28,500 live
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Individual 118 is the person described in this paper.
births. Sillence etal specified fourbasic types of
the disease, based on age-of-onset, severity and
modeoftransmission4.Thefamilydescribedmeet
the criteria for type I osteogenesis imperfecta.
Cardiovascular involvement in osteogenesis
imperfecta type I was describedin one study and
includes mitral valve prolapse in 18% with rare
progressiontomitralregurgitation, andslightbut
significant increase in aortic root diameter
associated with aortic regurgitation in 1 to 2%5.
Over 70 mutations have been associated with
osteogenesis imperfecta, all affecting type I
procollagen synthesis. The osteogenesis
imperfecta type I phenotype can be produced by
mutation in either the COLlAl gene on
chromosome 17 (17q21.3 1-q22) ortheCOL1A2
gene on chromosome 7 (7q22.1), andpossibly in
othergenes6.Thepresenceorabsenceofpresenile
hearing loss was the best predictor ofthe mutant
locus in osteogenesis imperfecta type I families
with 13 ofthe 17 COLlAl segregants and none
of the COL1A2 segregants demonstrating this
feature7.
The estimated incidence of both osteogenesis
imperfecta and supravalvular aortic stenosis
occurring together by chance in an individual is
over one in five hundred million. Although the
ELN and COL1A2 genes are both present on
chromosome 7, it is highly unlikely that the
coexistence inthe individuals discussedis dueto
expression ofone genetic defect for a number of
reasons. Firstly, theELN andCOL1A2 genes are
not closely linked on chromosome 7, and in the
knowledge that the individual discussed has a
normalkaryotype, alargedeletioncannotexplain
coexistence ofthediseases. Secondly, thefamily
described have had presenile hearing loss as a
featureofosteogenesisimperfecta, whichhasnot
been a feature ofmutation in the COL1A2 gene;
therefore itcanbepostulatedthatthemutationin
this case is linked to the COLlAl gene on
chromosome 17. Finally, the diseases have not
segregated together in this family, so there have
been some members with both osteogenesis
imperfectaandsupravalvularaorticstenosis,some
with only one disease and some with neither
disorder.
In conclusion, we present a case with coexisting
supravalvular aortic stenosis and osteogenesis
imperfecta, the first documentation in the
literature. Bothdiseases haveasinglegenebasis,
autosomal dominant transmission, altered
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production of structural proteins and
manifestation in the cardiovascular system. The
likelyhood ofpure chance association is low.
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